SHANGHAI – The U.S. and China hybrid startup MicuRx Pharmaceuticals Inc. announced Oct. 24 that it has formed a joint venture with Shanghai Zhangjiang Biomedical Industry Venture Capital (ZJVC)
In Vitro Diagnostics Alliances